Can a website replace your doctor for Alzheimer's risk news?
NCT ID NCT06459583
First seen Jan 14, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study tested whether an online platform can effectively share Alzheimer's gene and biomarker test results with participants, compared to a video call with a healthcare provider. 681 adults took part, and researchers measured their anxiety, distress, and understanding of the information. The goal was to see if self-guided online methods are a safe and effective alternative for delivering sensitive health risk information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Accellacare Clinical Research Site 01
Bristol, Tennessee, 37620, United States
-
Accellacare Clinical Research Site 02
Mt. Pleasant, South Carolina, 29464, United States
Conditions
Explore the condition pages connected to this study.